Tutorials
Natera Inc logo

Natera Inc

$ 53.59 -1.7 (-3.07%) 08:08 PM EST
P/E:
At Loss
P/B:
11.62
Market Cap:
$ 5.20B
Enterprise V:
$ 5.12B
Volume:
3.82M
Avg Vol (2M):
1.30M
Also Trade In:
Volume:
3.82M
Market Cap $:
5.20B
PE Ratio:
At Loss
Avg Vol (2-Month):
1.30M
Enterprise Value $:
5.12B
PB Ratio:
11.62
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Natera Inc
NAICS : 621511 SIC : 8071
13011 McCallen Pass, Building A Suite 100, Austin, TX, USA, 78753
Compare
Compare
GH OCDX NEOG LNTH MEDP OPK TWST MYGN FLGT SHC TMO DHR XSWX:LONN SHSE:603259 IQV ILMN A IDXX MTD LH
Traded in other countries / regions
45E.Germany NTRA.USA
Description
Natera Inc is operative in the healthcare field in the United States. Its core business is to offer invasive and other means of diagnosing the genetic features of a fetus. Natera's array of diagnostic services includes Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, Anora Products of Conception (POC) test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing (PAT), to determine paternity by studying the fragments of fetal deoxyribonucleic acid (DNA) in a pregnant mother's blood and a blood sample from the alleged father. The Company acquires its revenue by billing an insurance carrier, a clinic, or a patient for the test upon delivery of the test result.
Name Current Vs Industry Vs History
Cash-To-Debt 1.59
Equity-to-Asset 0.42
Debt-to-Equity 0.91
Debt-to-EBITDA -0.73
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.62
Distress
Grey
Safe
Beneish M-Score -2.07
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 81.73
9-Day RSI 77.39
14-Day RSI 72.92
6-1 Month Momentum % -45.98
12-1 Month Momentum % -63.35

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.58
Quick Ratio 3.46
Cash Ratio 2.54
Days Inventory 26.13
Days Sales Outstanding 71.52
Days Payable 19.19

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15.3

Financials (Next Earnings Date:2022-11-04 Est.)

NTRA's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:NTRA

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 723.477
EPS (TTM) ($) -6.07
Beta 1.48
Volatility % 61.5
14-Day RSI 72.92
14-Day ATR ($) 3.180369
20-Day SMA ($) 47.7285
12-1 Month Momentum % -63.35
52-Week Range ($) 26.1 - 129.09
Shares Outstanding (Mil) 96.96

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Natera Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More